- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03584672
The Reliability, Validity, and Responsiveness of the Static Balance Test in Patients With Multiple Sclerosis.
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Anticipated)
Contacts and Locations
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- at least 18 years,
- neurologist-diagnosed Multiple Sclerosis,
- Expanded Disability Status Scale (EDSS) score < 7,
- able to walk 10 m with or without aids,
- no MS exacerbation within the last 2 months,
- use of stable medication in the last 2 months,
Exclusion Criteria:
- other neurologic disorder,
- Pregnancy,
- orhopedic problems iaffecting gait and stance,
- visual, auditory, orientational problems that could affect study results,
- Cardiovascular, pulmonary, and humoral disease.
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Cross-Sectional
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Patients with Multiple Sclerosis
Patients with Multiple Sclerosis (Expanded Disability Status Scale (EDSS) score < 7)
|
Balance control is assessed by the Static Balance Test.
Functional balance is assessed by the Berg Balance Scale.
Functional mobility is assessed by the Timed Up and Go test.
Dynamic balance is assessed by the Four Square Step Test.
Limits of stability is assessed by the Functional Reach Test.
Postural steadiness is assessed by the One-leg Stance Test.
|
|
Healthy Controls
Healthy people
|
Balance control is assessed by the Static Balance Test.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Static Balance Test
Time Frame: 5 minutes
|
The Static Balance Test is used to assess balance control. The Static Balance Test, consists of five posture-holding tasks (sitting, stride standing, close standing, one-foot standing on the unparalyzed leg, and one-foot standing on the paralyzed leg). Four grades, 1-4, are used to judge the ability of patients to hold these postures. The grade at which a subject is rated on a task is taken as the score for that task. Hence, the minimum Static Balance Test score is 5, and the maximum is 20. A higher score indicates better balance. |
5 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Berg Balance Scale
Time Frame: 15 minutes
|
Functional balance is assessed by using the Berg Balance Scale.
During the test, participants are asked to perform 14 tasks frequently used in daily life activities.
Each item is scored between 0 (unable to perform the task) and 4 (task is performed independently) according to the ability of the person while performing the task.
The highest possible score is 56 points.
A higher score indicates better balance.
|
15 minutes
|
|
Timed Up and Go Test
Time Frame: 1 minutes
|
Functional mobility is assessed by using the timed up and go test.
The timed up and go test measures the time that a patient needs to stand up from a chair, walk a 3-m distance, come back and sit back on the chair.
A lower score indicates better functional mobility.
|
1 minutes
|
|
Four Square Step Test
Time Frame: 1 minutes
|
The Four Square Step Test measures dynamic balance and clinically assesses the person's ability to step over objects forward, sideways, and backward.
A square was formed by 4 canes resting flat on the floor.
The participants were instructed to try and complete the sequence as fast as possible without touching the canes with both feet, making contact with the floor in each square.
A lower score indicates better dynamic balance.
|
1 minutes
|
|
One-leg Stance Test
Time Frame: 5 minutes
|
The clinical test of One-leg Stance Test assesses postural steadiness in a static position by a quantitative measurement i.e. the number of seconds a person can maintain the One-leg Stance Test position, thus implying that better postural steadiness would allow for longer standing on one leg.
|
5 minutes
|
|
Functional Reach Test
Time Frame: 30 seconds
|
The Functional Reach Test assesses balance by measuring the limits while the patient reaches forwards as far as possible, having the arms in 90° flexion and without lifting the heels off the floor.
A higher score indicates better limits of stability.
|
30 seconds
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Fatih Söke, Gazi University
Publications and helpful links
General Publications
- Cattaneo D, Regola A, Meotti M. Validity of six balance disorders scales in persons with multiple sclerosis. Disabil Rehabil. 2006 Jun 30;28(12):789-95. doi: 10.1080/09638280500404289.
- McConvey J, Bennett SE. Reliability of the Dynamic Gait Index in individuals with multiple sclerosis. Arch Phys Med Rehabil. 2005 Jan;86(1):130-3. doi: 10.1016/j.apmr.2003.11.033.
- Gijbels D, Alders G, Van Hoof E, Charlier C, Roelants M, Broekmans T, Eijnde BO, Feys P. Predicting habitual walking performance in multiple sclerosis: relevance of capacity and self-report measures. Mult Scler. 2010 May;16(5):618-26. doi: 10.1177/1352458510361357. Epub 2010 Mar 5.
- Matsuda PN, Shumway-Cook A, Bamer AM, Johnson SL, Amtmann D, Kraft GH. Falls in multiple sclerosis. PM R. 2011 Jul;3(7):624-32; quiz 632. doi: 10.1016/j.pmrj.2011.04.015.
- Suzuki M, Fujisawa H, Machida Y, Minakata S. Relationship between the Berg Balance Scale and Static Balance Test in Hemiplegic Patients with Stroke. J Phys Ther Sci. 2013 Aug;25(8):1043-9. doi: 10.1589/jpts.25.1043. Epub 2013 Sep 20.
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 322
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Multiple Sclerosis
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis, Remittent ProgressiveJapan
-
University Hospital, Basel, SwitzerlandSwiss National Science FoundationRecruitingMultiple Sclerosis (MS) | Relapsing-remitting Multiple Sclerosis (RRMS) | Secondary-progressive Multiple Sclerosis (SPMS) | Primary Progressive Multiple Sclerosis (PPMS)Switzerland
-
University of California, Los AngelesUnknownRelapsing-remitting Multiple Sclerosis | Secondary-progressive Multiple Sclerosis | Primary-progressive Multiple SclerosisUnited States
-
Cabaletta BioNot yet recruitingProgressive Multiple Sclerosis | Multiple Sclerosis | Multiple Sclerosis (Relapsing Remitting) | Relapsing Multiple Sclerosis (RMS) | Progressive Multiple Sclerosis (PMS) | Multiple Sclerosis (MS) - Relapsing-remitting | Multiple Sclerosis - Relapsing Remitting
-
The Cleveland ClinicUniversity Hospitals Cleveland Medical CenterCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Progressive Relapsing Multiple SclerosisUnited States
-
Icahn School of Medicine at Mount SinaiColumbia University; New York Stem Cell Foundation Research InstituteCompletedClinically Isolated Syndrome | Relapsing-Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Rigshospitalet, DenmarkOdense University Hospital; Aarhus University Hospital; Hvidovre University Hospital and other collaboratorsActive, not recruitingRelapsing Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisDenmark
-
Novartis PharmaceuticalsCompletedRelapsing-remitting Multiple Sclerosis | Active Secondary Progressive Multiple SclerosisJapan
-
Banc de Sang i TeixitsVall d'Hebron Research Institute (VHIR)CompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisSpain
-
BiogenElan PharmaceuticalsCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
Clinical Trials on Static Balance Test
-
Pôle Saint HélierHopital La MusseCompleted
-
Aalborg University HospitalAalborg UniversityCompletedLow Back Pain, PosturalDenmark
-
Riphah International UniversityCompletedIntellectual ImpairmentPakistan
-
Jia-Ling HongRecruitingOlder Adults, Balance | Postural Balance | Balance AssessmentTaiwan
-
Centre Hospitalier Intercommunal de Toulon La Seyne...Université de ToulonCompletedChronic Obstructive Pulmonary Disease (COPD)France
-
Istanbul University - Cerrahpasa (IUC)UnknownParkinson Disease
-
Gazi UniversityCompletedMuscle Strength | Balance | Joint HypermobilityTurkey
-
Igdir UniversityActive, not recruitingChronic Ankle Instability, CAITurkey (Türkiye)
-
Marmara UniversityCompletedKyphosis | Balance; Distorted | Balance | Spine Disease | Postural KyphosisTurkey
-
Fatih Sultan Mehmet Training and Research HospitalCompletedAttention Deficit Hyperactivity DisorderTurkey